4Leung NWY,LaiCL,Chang TY,et al. Three year lamivudine therapy in chronic HBV. J Hepatology, 1999,30:59.
二级参考文献13
1Lai C L，Hepatology，1997年，25卷，241页
2Lai C L，J Hepatol，1997年，26卷，Suppl1期，79页
3Core Working Party For Asia-Pacific Consensus On Hepatitis B And C.Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region[].Journal of Gastroenterology.2000
4Niederau C,Heintges T,Lange S,et al.Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B[].The New England Journal of Medicine.1996
5Heathcote EJ,Jeffers L,Wright T,et al.Loss of serum HBV DNA and HBeAg and seroconversion following short-term ( 12 weeks) adefovir dipivoxil therapy in chronic hepatitis B: two placebo-controlled phase Ⅱ studies ( abstr )[].Hepatology.1998
6Pastore G,Santantonio T,Milella A,et al.Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum: respones to a 6month course of lymphoblastoid interferon[].Journal of Hepatology.1992
7Perrillo RP,Wright T,Rakela J,et al.A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B[].Hepatology.2001
8Chien RN,Liao YF,Chen TC,et al.Efficacy of thymosinα1 in patients with chronic type B hepatitis: a randomized controlled trial[].Hepatology.1998
9Chang TT,Lai CL,Liaw YF,et al.Incremental increases in HBeAg seroconversion and continued ALT normalization in Asian chronic HBV patients treated with lamivudine for four years(abstr)[].Antiviral Therapy.2000
10Hadziyannis S,Bramou T,Makris A,et al.Interferon alfa-2b treatment lf HBeAg negative serum HBV DNA positive chronic active hepatitis B[].Journal of Hepatology.1990
7Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
